Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma

Rebecca Diehl, Marlon Grodd, Valentina Bieneck, Adriana Lazarou, Frank Meiss, Saskia Lehr, David Rafei

doi:10.1016/j.ejcskn.2026.101170

CrossrefKarta ta’ informazzjoni

Influence of dosage and therapeutic interval on the incidence of severe side effects of immunotherapy with PD-1 inhibitors in malignant melanoma

Rebecca Diehl, Marlon Grodd, Valentina Bieneck, Adriana Lazarou, Frank Meiss, Saskia Lehr, David Rafei

EJC Skin Cancer · 2026 · 4 · 101170

DOI: 10.1016/j.ejcskn.2026.101170 ↗

Astratt Dettalji biblijografiċi

Astratt

Ebda abstract disponibbli.

Dettalji biblijografiċi

Awturi/Awturiċi: Rebecca Diehl, Marlon Grodd, Valentina Bieneck, Adriana Lazarou, Frank Meiss, Saskia Lehr, David Rafei
Ġurnal: EJC Skin Cancer
Sena tal-pubblikazzjoni: 2026
Volum / Ħarġa: 4
Paġni: 101170
Pubblikatur: Elsevier BV
DOI: 10.1016/j.ejcskn.2026.101170
ISSN: 2772-6118
Sors: Crossref

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.